These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Haemostasis alterations in coronary artery bypass grafting: comparison between the off-pump technique and a closed coated cardiopulmonary bypass system. Scrascia G; Rotunno C; Guida P; Conte M; Amorese L; Margari V; Schinosa Lde L; Paparella D Interact Cardiovasc Thorac Surg; 2013 May; 16(5):636-42. PubMed ID: 23335652 [TBL] [Abstract][Full Text] [Related]
6. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Estrada CA; Young JA; Nifong LW; Chitwood WR Ann Thorac Surg; 2003 May; 75(5):1392-9. PubMed ID: 12735552 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations. Franco LF; Szarf G; Dotto RP; Dib SA; Moises RS; Giuffrida FMA; Reis AF Diabetes Res Clin Pract; 2021 Jun; 176():108867. PubMed ID: 34023340 [TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia Aggravates Diet-Induced Coronary Artery Disease and Myocardial Infarction in SR-B1-Knockout/ApoE-Hypomorphic Mice. Gonzalez L; MacDonald ME; Deng YD; Trigatti BL Front Physiol; 2018; 9():1398. PubMed ID: 30356742 [TBL] [Abstract][Full Text] [Related]
9. Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope. He J; Bellenger NG; Ludman AJ; Shore AC; Strain WD Rev Cardiovasc Med; 2022 Jan; 23(1):23. PubMed ID: 35092215 [TBL] [Abstract][Full Text] [Related]
10. Admission hyperglycemia and all-cause mortality in diabetic and non-diabetic patients with acute myocardial infarction: a tertiary center analysis. Ferreira JA; Baptista RM; Monteiro SR; Gonçalves FM; Monteiro PF; Gonçalves LM Intern Emerg Med; 2021 Nov; 16(8):2109-2119. PubMed ID: 33713285 [TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Paolisso P; Foà A; Bergamaschi L; Donati F; Fabrizio M; Chiti C; Angeli F; Toniolo S; Stefanizzi A; Armillotta M; Rucci P; Iannopollo G; Casella G; Marrozzini C; Galiè N; Pizzi C Cardiovasc Diabetol; 2021 Feb; 20(1):33. PubMed ID: 33530978 [TBL] [Abstract][Full Text] [Related]
12. Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease. Paolisso P; Bergamaschi L; Saturi G; D'Angelo EC; Magnani I; Toniolo S; Stefanizzi A; Rinaldi A; Bartoli L; Angeli F; Donati F; Rucci P; Mattioli AV; Taglieri N; Pizzi C; Galiè N Front Pharmacol; 2019; 10():1606. PubMed ID: 32082147 [TBL] [Abstract][Full Text] [Related]
13. Impact of Hyperglycemia on Long-Term Outcome in Patients With ST-Segment Elevation Myocardial Infarction. Kojima T; Hikoso S; Nakatani D; Suna S; Dohi T; Mizuno H; Okada K; Kitamura T; Kida H; Oeun B; Sunaga A; Kurakami H; Yamada T; Sakata Y; Sato H; Hori M; Komuro I; Sakata Y; Am J Cardiol; 2020 Mar; 125(6):851-859. PubMed ID: 31964502 [TBL] [Abstract][Full Text] [Related]